mybacs

📍 Zug, Switzerland🗓 Founded 2019👥 50 employees💰 Last funded Sep 2025
mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.
5
Total investors
3
Early stage
0
Mid stage
2
Late stage
2019
Founded
Investor geography3 countries
Germany
3
United States
1
United Kingdom
1
Investor activity2019–2025 · investors recorded per year
201922021120252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in mybacs?
mybacs has 5 investors on record on gritt.io, including 3 early-stage backers and 2 late-stage investors.
When did mybacs last raise funding?
The most recent investment in mybacs recorded on gritt.io was in September 2025.
When was mybacs founded?
mybacs was founded in 2019.
What industry is mybacs in?
mybacs operates in Retail Health and Personal Care Products. Find similar Retail Health and Personal Care Products investors on gritt.io.
Where is mybacs based?
mybacs is headquartered in Zug, Switzerland.